Actionable news
0
All posts from Actionable news
Actionable news in ESPR: Esperion Therapeutics, Inc.,

Esperion Therapeutics, Inc. (ESPR)

DateInsiderSharesTypeTransactionValue*
Mar 1, 2016OMENN GILBERT SDirector5,000DirectPurchase at $15.28 - $15.28 per share.76,0002
Jan 27, 2016MAYLEBEN TIMOTHY MOfficer3,600DirectPurchase at $15.88 - $15.88 per share.57,0002
Jan 15, 2016MAYLEBEN TIMOTHY MOfficer7,200DirectPurchase at $14.08 - $14.08 per share.101,0002
Aug 19, 2015MCGOWAN MARYOfficer15,000DirectAcquisition (Non Open Market) at $0 per share.N/A
Jun 15, 2015BRAUNSTEIN SCOTTDirector52DirectStatement of OwnershipN/A
Apr 28, 2015GOLDSTEIN DOV A MDDirector199,991IndirectDisposition (Non Open Market) at $0 per share.N/A
Apr 24, 2015GOLDSTEIN DOV A MDDirector67,469IndirectSale at $106.10 - $108 per share.7,223,0002
Apr 24, 2015AISLING CAPITAL II LPBeneficial Owner (10% or more)67,469IndirectSale at $106.10 - $108 per share.7,223,0002
Apr 23, 2015GOLDSTEIN DOV A...

More